Cargando…
PPA1 Deficiency Causes a Deranged Galactose Metabolism Recognizable in Neonatal Screening
Two siblings showed increased galactose and galactose-related metabolites in neonatal screening. Diagnostic workup did not reveal abnormalities in any of the known disease-causing enzymes involved in galactose metabolism. Using whole-exome sequencing, we identified a homozygous missense variant in P...
Autores principales: | Achleitner, Melanie T., Jans, Judith J. M., Ebner, Laura, Spenger, Johannes, Konstantopoulou, Vassiliki, Feichtinger, René G., Brugger, Karin, Mayr, Doris, Wevers, Ron A., Thiel, Christian, Wortmann, Saskia B., Mayr, Johannes A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10673274/ https://www.ncbi.nlm.nih.gov/pubmed/37999237 http://dx.doi.org/10.3390/metabo13111141 |
Ejemplares similares
-
Case Report—An Inherited Loss-of-Function NRXN3 Variant Potentially Causes a Neurodevelopmental Disorder with Autism Consistent with Previously Described 14q24.3-31.1 Deletions
por: Feichtinger, René G., et al.
Publicado: (2023) -
The Switch in the Diagnosis of Mitochondrial Diseases from the Classical ‘Function First’ To the NGS-based ‘Genetics First’ Diagnostic Era
por: Sperl, Wolfgang, et al.
Publicado: (2020) -
Molekulare Medizin: Pathobiochemie als Schlüssel zur personalisierten Therapie vererbter Krankheiten
por: Mayr, J. A., et al.
Publicado: (2021) -
A TSHZ3 Frame-Shift Variant Causes Neurodevelopmental and Renal Disorder Consistent with Previously Described Proximal Chromosome 19q13.11 Deletion Syndrome
por: Feichtinger, René G., et al.
Publicado: (2022) -
A spoonful of L‐fucose—an efficient therapy for GFUS‐CDG, a new glycosylation disorder
por: Feichtinger, René G, et al.
Publicado: (2021)